To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
Prostate CancersBreast CancerHead and Neck CancerCancer
Study summary
This registry study aims to evaluate the effectiveness and clinical impact of specimen PET-CT imaging by analyzing the correlation between specimen PET-CT images, intraoperative interpretations, and histopathological findings. Additionally, it assesses how these imaging insights influence clinical decision-making and long-term patient outcomes. Through this comprehensive analysis in a real-world setting, the study seeks to generate valuable insights that can enhance specimen evaluation processes and ultimately improve patient care.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria :
All patients that were scheduled for resective surgery and for whom successful high-resolution PET-CT imaging was performed on their resected specimens using the AURA 10 PET-CT. Successful imaging means that the image contains at least a portion of the primary tumor, the radiotracer injection was correctly executed and there were no technical issues that lead to an uninterpretable PET-CT image. Or all patients that are scheduled for resective surgery and for whom high-resolution PET-CT imaging will be performed on their resected specimens using the AURA 10 PET-CT.
Patients willing to provide informed consent for use of their relevant medical records. For retrospectively included patients with no further Long-Term Follow-Up (LTFU) data collection, a notification will be sent.
Exclusion Criteria:
* Under the age of 18 years at the time of resective surgery.
* Women who are pregnant or breastfeeding.
Primary outcome measure(s)
To assess the correlation between the specimen PET-CT images and final histopathological examination of the specimen. — Perioperative The concordance rate between the specimen PET-CT images and final histopathological examination of the specimen.
Trial sites (5)
Facility
City
Region
Status
AZORG
Aalst
Belgium
Not Yet Recruiting
AZ Maria Middelares
Ghent
Belgium
Recruiting
Universitäts-klinikum Essen
Essen
North Rhine-Westphalia
Recruiting
UMCG
Groningen
Netherlands
Recruiting
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust
Coventry
West Midlands
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.